Osteoarthritis (OA) of the knee is the most common form of arthritis, affecting 30 million Americans and 500 million globally. There are currently no drugs or other treatments available for OA.
Read More
Peripheral artery disease affects around 1 in 20 Americans over the age of 50, occurring when blood flow is limited by blocked arteries. The patients were treated with the implantation of a Human Acellular Vessel (HAV), a bioengineered tissue, to from Humacyte to facilitate revascularization.
Read More
The trial, expected to begin enrolling patients in the fourth quarter 2019, will test combining Heat’s engineered HS-130 and HS-110 cell lines.
Read More
Raligh-based RedHIll Biopharma expects results of its clinical trials of drugs for Crohn’s Disease and H. pylori infections before year’s end.
Read More
